OpenAI-backed biotech firm Chai Discovery raises $130M Series B at $1.3B valuation

Chai is building foundation models for drug discovery, specifically to predict interactions between molecules so they could be reprogramed for cures.

Dejar un comentario

Tu dirección de correo electrónico no será publicada. Los campos obligatorios están marcados con *

Review Your Cart
0
Add Coupon Code
Subtotal